search

Our Achievements

pharma & biotech

Monoclonal antibodies (mAbs) production unit

project essentials

Boccard carried out the studies and the supply of equipment for two new downstream monoclonal antibodies production workshops, for the Korean pharmaceutical company Aprogen, at its Osong plant. This project was carried out in collaboration with the company Yunsung, Boccard's Korean partner.

key points

International collaboration
Use of virtual reality
19 skids
68 stainless steel tanks

equipment supplied

  • 13 process skids including 48 tanks from 800 L to 7000 L with their associated platform
  • 6 cleaning skids including 20 stainless steel tanks of 1800 L
  • 4 plastic tanks for acid and soda storage for cleaning

for further information

Boccard was chosen for its expertise in monoclonal antibodies and disinfection as well as for its know-how in GMP design (good manufacturing practices).

For this project, Boccard joined forces with its Korean partner Yunsung: while Boccard took care of all the design, project management and procurement, Yunsung carried out the construction of the installation (with plans made by Boccard). The Boccard teams went to the factory in Korea to commission the installation.

In order to facilitate international communication, the teams were equipped with a virtual reality software allowing them to perform collaborative and remote model reviews, thus making it easy to work with the end customer located in Korea.

OUR ACHIEVEMENTS

For Pharma & Biotech industries

PROJET
Increase production capacities in a recombinant protein production plant

In order to increase the production capacity of this Belgian biotechnology company, Boccard designed and supplied a complete unit for the production of recombinant proteins.

Read more
PROJET
R&D fermentation platform for the production of hyaluronic acid

Boccard carried out the design, manufacture, qualification and commissioning of a fermentation platform with a capacity of 1000L.

Read more
PROJET
Transfer and increase production capacity of 2 blood fractionation workshops

To increase its production capacity for plasma-derived drugs, LFB called on Boccard Health & Care.

Read more
Follow us
Quick navigation
Copyright Boccard 2021 / All rights reserved
CookiesLegal NoticeGDRP
arrow-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram